The largest database of trusted experimental protocols

19 protocols using p5585

1

Human Umbilical Vein Endothelial Cells Responses to Palmitic Acid and Omentin-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) were obtained from Procell (CL-0122) and cultured in Dulbecco's modified Eagle's medium (DMEM, HyClone) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P/S). Cells from passages 3 to 8 were used for experiments. Palmitic acid (PA; P5585, Sigma), a representative FFA in vivo, was prepared in dimethyl sulfoxide (DMSO). Confluent HUVECs were serum-starved for overnight in non-FBS DMEM, and then the medium was replaced with FBS-containing DMEM. HUVECs were incubated with PA and/or recombinant human omentin-1 (9137-IN-050, R&D) as follows: control (0 mM PA in phosphate-buffered saline [PBS]), DMSO (0 mM PA in DMSO), 1 mM PA, 1 mM PA + 100 ng/mL omentin-1, 1 mM PA + 150 ng/mL omentin-1, or 1 mM PA + 200 ng/mL omentin-1 for 24 h.
THP-1 cells were purchased from Procell (CL-0233) and cultured in Roswell Park Memorial Institute (RPMI)-1640 (HyClone) medium supplemented with 15% FBS and 1% P/S. Cells from passages 3 to 5 were used for experiments.
+ Open protocol
+ Expand
2

Culturing HUVECs with Palmitic Acid and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) were cultured as previously described (Xu et al. 2017b (link)). In some experiments, HUVECs were incubated with 0.1–0.5 mM palmitic acid (PA, P5585, Sigma-Aldrich, St. Louis, MO, USA), 2–20 μM ABT702 (2372, Tocris Bioscience, Bristol, United Kingdom), 5 μM ZM241385 (1036, Tocris Bioscience, Bristol, United Kingdom), 5 μM MRS1754 (2752, Tocris Bioscience, Bristol, United Kingdom) or 10 μM ITU (1745, Tocris Bioscience, Bristol, United Kingdom). Adenoviral transduction of HUVECs was performed as previously described (Xu et al. 2017b (link)). Palmitate-BSA complex was prepared as previously described (Maloney, et al. 2009 (link)).
+ Open protocol
+ Expand
3

Huh-7 Cells Lipid Metabolism Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Huh-7 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% (v/v) heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, in a humidified atmosphere containing 5% CO2 at 37 °C. For experimental purposes, cells (2–3 × 106) were seeded in 100 mm culture dishes and, after 24 h, the culture medium was carefully removed and cells were washed twice with phosphate-buffered saline (PBS). Then, cells were treated for 16 h with 400 µM fatty acids (PA or OA), or Tg (2.5 nM), or SCD1i (5 µM) or vehicle (0.2% ethanol + 0.01% DMSO). Palmitic acid (P5585, Sigma-Aldrich) and oleic acid (O1008, Sigma-Aldrich) were dissolved in ethanol at a stock concentration of 148 mM; final concentration of ethanol was 0.2% in the medium. Tg (T9033, Sigma-Aldrich) and SCD1i (sc-205109A, Santa Cruz Biotechnology) were dissolved in DMSO at a stock solution of 2 mM and 25 mM, respectively; final concentration of DMSO was ≤ 0.01% in the medium. All treatments were carried out in serum-free medium containing 0.1% free fatty acids-Bovine Serum Albumin. Media were collected to isolate EVs by a differential centrifugation26 (link),45 (see below). Cells were recovered and counted by Countess TC20 automated cell counter (Bio-Rad). Cell viability was assessed by Trypan Blue stain exclusion.
+ Open protocol
+ Expand
4

Palmitic Acid-BSA Conjugate Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We dissolved 25.6 mg palmitic acid (PA, Sigma Aldrich P5585) into 1 mL 0.15 M NaCl at 70ºC in a shaking heat block
to make 100 mM PA. We added the PA solution dropwise into 10% w/v BSA in 0.15 M NaCl at 37ºC to make PA:BSA conjugate at 8
mM stock PA.
+ Open protocol
+ Expand
5

Fatty Acid Treatment of IPEC-J2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
IPEC-J2 cells were maintained in Dulbecco’s modified Eagle medium (DMEM) with GlutaMAX (31966-021, Gibco) supplemented with 10% fetal bovine serum (HyClone, SH30066.03) and 1% penicillin/streptomycin (100 U/mL/100 𝜇g/mL) in a humidified atmosphere of 5% CO2 at 37°C. The medium was changed every 2–3 days. The cells were passaged once a week and seeded at a density of 100,000 cells/cm2. Once they reached confluence, IPEC-J2 cells were treated for 3 days with 250 µM of either C12:0 (Sigma-Aldrich, L4250), C14:0 (Sigma-Aldrich, M3128), C16:0 (Sigma-Aldrich, P5585), or C18:0 (Sigma-Aldrich, S4751) diluted in dimethylsulfoxide (DMSO; Sigma-Aldrich, D8418) to a final concentration of 0.6%. The control condition (CTRL) corresponds to the IPEC-J2 treated for 3 days with 0.6% DMSO. The treatment was changed every day.
+ Open protocol
+ Expand
6

Palmitic Acid-BSA Conjugate Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We dissolved 25.6 mg palmitic acid (PA, Sigma Aldrich P5585) into 1 mL 0.15 M NaCl at 70ºC in a shaking heat block
to make 100 mM PA. We added the PA solution dropwise into 10% w/v BSA in 0.15 M NaCl at 37ºC to make PA:BSA conjugate at 8
mM stock PA.
+ Open protocol
+ Expand
7

Preparation of Fatty Acid Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The C16:0 (derived from vegetable) (purity ≥ 99%; Sigma, P5585, China) and C20:5 (derived from fish oil) (purity ≥ 98.5%; Sigma, 44864, China) solutions were prepared following the method of Elsner et al. (Elsner et al., 2011 (link), Plotz et al., 2016 (link)). Briefly, a 50 mM stock solution was prepared for both C16:0 and C20:5 using 90% ethanol, and heated at 60°C for 5 mins. Then, fatty acids were bound to 2% fatty acid‐free bovine serum albumin (BSA) (Aladdin, B265986, China) in RPMI 1640 culture medium supplemented with 1% FBS. The final BSA:fatty acids ratio was 2% BSA:1 mM fatty acids. Before treatment with pTr2 and PIEC, 1 mM fatty acids were diluted to the respective concentrations in serum‐free basic RPMI 1640 medium.
+ Open protocol
+ Expand
8

Palmitic Acid-Induced Stress in H9C2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9C2 cells, a myoblastic cell line derived from embryonic BD1X rat myocardium, were obtained from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences (Shanghai, China) and cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) in a humidified atmosphere of 5% CO2 at 37 °C. Various concentration of palmitic acid (PA, P5585, Sigma) in 1% fat-free bovine serum albumin (BSA, Roche) was prepared. The cells were treated with 0.4 mM PA for various time points or with various concentrations of PA for 12 hrs. For vehicle control, H9C2 cells were incubated with 1% fat-free BSA solution. Chloroquine (CQ, C6628, Sigma), 3-methyladenine (3-MA, HY-19312, MCE), sodium selenate (S8295, Sigma) were dissolved in phosphate buffer saline (PBS); and rapamycin (Rapa, HY-10219, MCE) and LY294002 (NSC 697286, MCE) was dissolved in DMSO. All reagents were diluted to the indicated concentrations.
+ Open protocol
+ Expand
9

Gradual Adaptation to Palmitic Acid

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded on 10 cm culture dishes so that the confluency at the starting day of adaptation was 80–90%. To start adaptation, all media was removed and replaced by growth media supplemented with palmitic acid (PA) (Sigma, P5585) and 1% fatty acid-free BSA as a carrier (Sigma, A7030). Adaptation was done using gradual increase in PA concentration MDA-MB-231 (50 µM, 200 µM and 400 µM, HCC1806 (200 µM and 400 µM), E0771 (200 µM, 400 µM, 500 µM) ensuring around 50% of cell death at each step. Parental cells were cultured in parallel using growth media supplemented only with 1% fatty acid-free BSA (Sigma, A7030).
For PA supplemented media, PA was first dissolved in absolute ethanol to obtain a 50 mM stock. To prepare the working concentrations, certain volumes of PA stock were added into 1%BSA growth media and incubated at 37 °C for 1 h. PA stock was stored at 4 °C and used for no longer than 2 weeks.
+ Open protocol
+ Expand
10

NEFA-Induced Dose-Dependent Effects on BGCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NEFA stock (50 mM) solution contained oleic acid (21.75 mM, O1008, Sigma, St. Louis, MO, USA), linoleic acid (2.45 mM, L1376, Sigma, USA), palmitic acid (15.95 mM, P5585, Sigma, USA), stearic acid (7.2 mM, S4751, Sigma, USA), and palmitoleic acid (2.65 mM, P9417, Sigma, USA), which were dissolved with potassium hydroxide (0.1 M) at 60 °C, and the pH of the NEFA solution was adjusted to 7.4 using hydrochloric acid (1 M). To test the dose-dependent effect of NEFA in BGCs, the cells were seeded in 96-well plates and treated for different concentrations of NEFA (0, 0.3, 0.6, 0.9, 1.2, 1.5, 1.8, 2.1, and 2.4 mM) at 37 °C for 12 and 24 h. The optimum NEFA treatment concentration and processing time were selected and used for the subsequent experiment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!